On May 14, 2026, A scientific team funded by the National Institutes of Health (NIH) has isolated and mapped in detail the first comprehensive group of human antibodies targeting the measles virus. The findings reveal previously unknown details about how the human immune system fights measles and identify specific antibodies capable of reducing the virus to undetectable levels in an animal model.
What the source shows
The research could serve as the foundation for development of a measles treatment. More than 470,000 measles cases were reported globally in 2024, and at least 72 outbreaks have been recorded in the United States since January 2025. From those cells, the team engineered and purified more than 100 individual human monoclonal antibodies, each targeting a specific site on the measles virus. Most strikingly, one antibody targeting the F protein, designated 4F09, was the single most protective antibody in the study, reducing measles virus levels in the lungs of infected rats to completely undetectable levels.
Why it matters
Measles cases have recently increased in the United States and worldwide. Taubenberger, M.D., Ph.D., acting director of NIH’s National Institute of Allergy and Infectious Diseases. “This research gives us a clear picture for the first time of the most promising targets for antibody-based medicines that could protect or treat people for whom measles vaccination is not an option." Previous research into measles immunity had relied largely on mouse antibodies and indirect methods, leaving the human antibody response poorly understood and structurally uncharacterized. Erica Ollmann Saphire of the La Jolla Institute for Immunology, isolated memory B cells—the immune cells that retain long-term "memory" of past infections or vaccinations—from a donor who had been vaccinated for measles three times. Using cutting-edge cryo-electron microscopy, the scientists produced the first-ever atomic-resolution structural maps of human antibodies bound to measles virus proteins, identifying nine distinct sites on the virus's two surface proteins, Hemagglutinin (H) and Fusion (F), that the antibodies targets.
Key Questions
Q: What happened or was found?
A: On May 14, 2026, A scientific team funded by the National Institutes of Health (NIH) has isolated and mapped in detail the first comprehensive group of human antibodies targeting the measles virus. The findings reveal previously unknown details about how the human immune system fights measles and identify specific...
Q: What concrete evidence or constraint does the source provide?
A: The findings reveal previously unknown details about how the human immune system fights measles and identify specific antibodies capable of reducing the virus to undetectable levels in an animal model.
Source: Researchers identify first suite of human antibodies against measles virus
Domain: nih.gov
Comments load interactively on the live page.